These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7486053)

  • 1. Intraoperative rhabdomyolysis in a patient receiving pravastatin, a 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase inhibitor.
    Rosenberg AD; Neuwirth MG; Kagen LJ; Singh K; Fischer HD; Bernstein RL
    Anesth Analg; 1995 Nov; 81(5):1089-91. PubMed ID: 7486053
    [No Abstract]   [Full Text] [Related]  

  • 2. HMG-CoA reductase inhibitor treatment in renal insufficiency.
    Wanner C
    Nephrol Dial Transplant; 1996 Oct; 11(10):1951-2. PubMed ID: 8918704
    [No Abstract]   [Full Text] [Related]  

  • 3. Mitochondrial myopathy developing on treatment with the HMG CoA reductase inhibitors--simvastatin and pravastatin.
    England JD; Walsh JC; Stewart P; Boyd I; Rohan A; Halmagyi GM
    Aust N Z J Med; 1995 Aug; 25(4):374-5. PubMed ID: 8540887
    [No Abstract]   [Full Text] [Related]  

  • 4. Massive postoperative rhabdomyolysis following combined CABG/abdominal aortic replacement: a possible association with HMG-CoA reductase inhibitors.
    Wilhelmi M; Winterhalter M; Fischer S; Walles T; Zuk J; Strüber M; Haverich A
    Cardiovasc Drugs Ther; 2002 Sep; 16(5):471-5. PubMed ID: 12652117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhabdomyolysis and statin therapy: relevance to the elderly.
    Sica DA; Gehr TW
    Am J Geriatr Cardiol; 2002; 11(1):48-55. PubMed ID: 11773716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rhabdomyolysis probably caused by interaction between efalizumab and pravastatin].
    Cid Conde L; Silveria Cancela D
    Farm Hosp; 2007; 31(2):135-6. PubMed ID: 17590128
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia.
    Hsu I; Spinler SA; Johnson NE
    Ann Pharmacother; 1995; 29(7-8):743-59. PubMed ID: 8520093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rhabdomyolysis and acute renal failure secondary to statins].
    Borrego FJ; Liébana A; Borrego J; Pérez del Barrio P; Gil JM; García Cortés MJ; Sánchez Perales C; Serrano P; Pérez Bañasco V
    Nefrologia; 2001; 21(3):309-13. PubMed ID: 11471312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerivastatin-induced rhabdomyolysis: 11 case reports.
    Ravnan SL; Locke C; Yee WP; Haase K
    Pharmacotherapy; 2002 Apr; 22(4):533-7. PubMed ID: 11939690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of pravastatin on hepatic 3-hydroxy-3-methylglutaryl CoA reductase obtained from poloxamer 407-induced hyperlipidemic rats.
    Johnston TP; Palmer WK
    Pharmacotherapy; 1997; 17(2):342-7. PubMed ID: 9085326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rhabdomyolysis reports show interaction between simvastatin and CYP3A4 inhibitors.
    Rowan C; Brinker AD; Nourjah P; Chang J; Mosholder A; Barrett JS; Avigan M
    Pharmacoepidemiol Drug Saf; 2009 Apr; 18(4):301-9. PubMed ID: 19206087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rhabdomyolysis caused by pravastatin and type 1 macrocreatine kinase].
    Decoulx E; Millaire A; de Groote P; Mahieux G; Ducloux G
    Ann Cardiol Angeiol (Paris); 1993 May; 42(5):267-9. PubMed ID: 8368799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pravastatin-induced rhabdomyolysis in a patient with mixed connective tissue disease.
    Hino I; Akama H; Furuya T; Ueda H; Taniguchi A; Hara M; Kashiwazaki S
    Arthritis Rheum; 1996 Jul; 39(7):1259-60. PubMed ID: 8670341
    [No Abstract]   [Full Text] [Related]  

  • 14. Statins and cancer development.
    Duncan RE; El-Sohemy A; Archer MC
    Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):1897-8. PubMed ID: 16103434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localized rhabdomyolysis after exertion in a cardiac transplant recipient on statin therapy.
    Biggs MJ; Bonser RS; Cram R
    J Heart Lung Transplant; 2006 Mar; 25(3):356-7. PubMed ID: 16507432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatal rhabdomyolysis following the co-prescription of fusidic acid and pravastatin.
    Bachoumas K; Fiancette M; Lascarrou JB; Lacherade JC; Leclair F; Reignier J
    Med Mal Infect; 2015 Oct; 45(10):417-9. PubMed ID: 26472060
    [No Abstract]   [Full Text] [Related]  

  • 17. Asymptomatic statin-induced rhabdomyolysis after long-term therapy with the hydrophilic drug pravastatin.
    Schindler C; Thorns M; Matschke K; Tugtekin SM; Kirch W
    Clin Ther; 2007 Jan; 29(1):172-6. PubMed ID: 17379057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymyalgia, hypersensitivity pneumonitis and other reactions in patients receiving HMG-CoA reductase inhibitors: a report of ten cases.
    Liebhaber MI; Wright RS; Gelberg HJ; Dyer Z; Kupperman JL
    Chest; 1999 Mar; 115(3):886-9. PubMed ID: 10084510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the effect of the 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors simvastatin, lovastatin and pravastatin on leukaemic and normal bone marrow progenitors.
    Newman A; Clutterbuck RD; Powles RL; Catovsky D; Millar JL
    Leuk Lymphoma; 1997 Feb; 24(5-6):533-7. PubMed ID: 9086443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generalized eczematous skin rash possibly due to HMG-CoA reductase inhibitors.
    Krasovec M; Elsner P; Burg G
    Dermatology; 1993; 186(4):248-52. PubMed ID: 8513188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.